$MAJI — the telehealth company with which we are finalizing a definitive agreement — is currently renegotiating terms with 1,900 clinics to expand its role as sole distributor beyond testosterone. The existing testosterone program alone generates approximately $4 per script across an estimated 2,000 daily prescriptions, highlighting meaningful revenue potential with significant upside as the partnership broadens.
Market Data 
Markets 
AI
